Transcranial magnetic stimulation participants for Healthy Subjects

Brown University, Providence, RI
transcranial magnetic stimulationN/AWaitlist AvailableLed by John A Westbrook, PhDResearch Sponsored by Brown University

Study Summary

This trial tests how brain activity changes when doing hard tasks and when exposed to magnetic stimulation.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have normal or corrected vision.
You are deemed to be in good health with no known neurological or medical conditions.
You use your right hand dominantly.


Screening ~ 3 weeks
Treatment ~ Varies
Follow ups ~ this baseline measurement will be made once, 20 minutes before stimulation, during each participant's first transcranial magnetic stimulation session.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this baseline measurement will be made once, 20 minutes before stimulation, during each participant's first transcranial magnetic stimulation session. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Avalanche duration statistics - dissipated effects of sham stimulation
Avalanche duration statistics - dissipated effects of target stimulation
Avalanche duration statistics - immediate effects of sham stimulation
+18 more
Secondary outcome measures
E/I balance - dissipated effects of sham stimulation
E/I balance - dissipated effects of target stimulation
E/I balance - immediate sham stimulation effects
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial magnetic stimulation participantsExperimental Treatment1 Intervention
All participants will be recruited into a single arm where, across two sessions they will receive transcranial magnetic stimulation in separate session to either the dorsolateral prefrontal cortex or the angular gyrus. Session order will be counter-balanced across participants, and stimulation target will be blinded to the participants until after their participation is complete.
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial magnetic stimulation
Completed Phase 2

Find a site

Who is running the clinical trial?

Brown UniversityLead Sponsor
438 Previous Clinical Trials
525,017 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,664 Previous Clinical Trials
1,983,920 Total Patients Enrolled
John A Westbrook, PhDPrincipal Investigator
Brown University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to participate in this experiment?

"The data published on indicates that this trial is actively searching for patients to participate in it. It was initially posted on April 1st 2023, and the latest version of the study was up-to-date as of March 31st 2023."

Answered by AI

Does this experimental program encompass individuals older than 25 years old?

"According to the inclusion criteria, participants must range between 18 and 45 years of age. For minors, there are 54 separate trials while those over 65 can access 369 different studies."

Answered by AI

What are the eligibility requirements to participate in this research?

"To be considered eligible for this trial, aspiring participants must fit the criteria of healthy individuals aged 18-45 years old. 30 volunteers are required to complete the experiment."

Answered by AI

What is the participant pool size for this clinical examination?

"Affirmative. According to the information available on, recruitment for this medical study is ongoing; it was initially posted in April 1st 2023 and lastly updated on March 31st of the same year. A total of thirty individuals are needed from one site alone."

Answered by AI

What objectives does this clinical trial hope to accomplish?

"This trial's primary aims are to measure the immediate effects of target stimulation and gauge participants' functional excitation-inhibition balance (E/I Balance) 20 minutes before their first transcranial magnetic stimulation session. Secondary objectives include quantifying how prolonged target or sham stimulations impact E/I balances, with a focus on assessing any protracted recovery following either type of treatment."

Answered by AI
~20 spots leftby Sep 2024